What are the responsibilities and job description for the Associate Director - Medical Writing Job at Novo Nordisk A/S in Lexington position at Novo Nordisk A/S?
Our East Coast Global Development Hub brings together the best minds in life science innovation with facilities in Lexington, MA and Plainsboro, NJ. We support programs from early research through late-stage clinical development. We are building for the future, creating a distinct R&D community based on collaboration, partnerships, and cutting-edge research across multiple innovative modalities and therapeutic areas. Our East Coast Global Development Hub merges biotech speed and agility with large pharmaceutical company quality, resources, and stability, uniting the best of both worlds to develop new medicines for patients. We recognize that improving human health starts here and that patients rely on us. We’re changing lives for a living. Are you ready to make a difference?
The Position
The Associate Director is an expert in medical writing and performs work independently with minimal-to-no supervision. The Associate Director will work closely with cross-functional project teams, including Medical & Science, Clinical Operations, Biometrics, and Regulatory Affairs personnel, to manage preparation of the written deliverables that support the clinical development and regulatory requirements of a clinical program. The Associate Director will provide high level strategic input into development plans, study designs, and regulatory submissions.
Relationships
The Associate Director, Medical Writing (ADMW) reports to a Director of Medical Writing. The Associate Director is expected to develop and maintain a strong network of internal relationships with global and local cross-functional study teams.
The Associate Director should be seen as a key resource for medical writing expertise and provides active leadership on local and global project teams, as needed.
The Associate Director will provide mentoring and direction to less-experienced medical writers, as needed. The Associate Director may supervise other members of the Medical Writing team.
Essential Functions
- Provides strategic input into documents and plans to support clinical operations and regulatory submissions across a range of development programs and therapeutic areas :
Uses professional experience to provide advanced input into study designs, analysis plans, and regulatory submissions / applications
Clinical summary and overview documents in eCTD format for global regulatory submissions, including investigational medicinal product dossiers (IMPD), investigational new drug applications (IND), clinical trial applications (CTA), marketing authorization applications (MAA), and new drug applications (NDA)
Shares project specific and general medical writing practices with other Medical Writers and contributes to process improvements within the project area and globally
Provides leadership in local and global project teams, facilitates collaboration, and drives decision making
Physical Requirements
Approximately 10% overnight travel. May include travel outside the US.
Development of People
Ensure that reporting personnel have individual development plans (IDP), with annual goals and measurements that are consistent with the priorities of the business, and that interim reviews are held so that their work is focused on those priorities, and they understand their level of accountability for results and the measurement process.
Ensure that the IDP forms include completed learning and aspiration plans and are in place for all reporting personnel to enable the achievement of goals and capability to assume increased levels of responsibility.
Manage the application and communication of all Novo Nordisk policies, procedures, and Novo Nordisk Way.
Qualifications
Requires 9 years of relevant experience. Minimum of 8 years clinical / regulatory medical writing experience in a pharmaceutical, biotechnology, or CRO environment
Demonstrated understanding of clinical research, the drug / device development process, and applicable regulatory guidelines
J-18808-Ljbffr